Veru's drug lessens loss of lean mass in pa­tients tak­ing We­govy

4 months ago
R&D

Al­lakos re­struc­tures af­ter Phase 1 fail­ure; AB2 inks deal with Nip­pon Shinyaku

4 months ago
News Briefing

Cell ther­a­py start­up Au­ri­on files for IPO, de­spite on­go­ing le­gal bat­tle with in­vestor Al­con

4 months ago
Financing
Cell/Gene Tx

Met­sera out­lines $250M IPO plans as obe­si­ty biotech com­pe­ti­tion ris­es

4 months ago
Financing
Startups

Ex­clu­sive: Leerink builds health­care M&A team, poach­ing deal­mak­ers from ri­vals

4 months ago
People
Deals

Maze looks to lead IPO queue with $113M Nas­daq de­but

4 months ago
Financing
Startups

Up­dat­ed: Akero re­deems its fail­ure in se­vere MASH with longer-term da­ta

4 months ago
R&D

Ei­sai and Bio­gen win ap­proval for once-month­ly Leqem­bi main­te­nance dos­ing

4 months ago
Pharma
FDA+

UK biotech launch­es with T cell ther­a­py tech­nol­o­gy to treat sol­id tu­mors

4 months ago
Startups
Cell/Gene Tx

Agenus con­tin­ues part­ner­ship talks for an­ti-CT­LA-4 com­bo with new Phase 2 da­ta

4 months ago
Deals
R&D

Bio­gen par­ing back re­search ef­forts; Will Chi­nese biotechs threat­en US dom­i­nance?; What the new ad­min­is­tra­tion means ...

4 months ago
Weekly

With Sam Alt­man’s help, Retro Bio­sciences eyes $1B to ex­tend lifes­pan by 10 years

4 months ago
Financing
Startups

Mer­ck and Ei­sai re­veal late-stage fail for Keytru­da and Lenvi­ma in gas­troe­sophageal can­cer

4 months ago
R&D
Pharma

Up­com­ing PDU­FA dates may be en­snared by Trump's pause at HHS, an­a­lyst says

4 months ago
FDA+

Take­da dis­con­tin­ues US sup­ply of gout drug Uloric over gener­ic com­pe­ti­tion 

4 months ago
Pharma
Manufacturing

The cru­cial obe­si­ty da­ta to watch for this year

4 months ago
R&D

Boehringer merges can­cer vac­cine and on­colyt­ic virus teams; Dan­tari sells off as­sets

4 months ago
News Briefing

As­traZeneca al­lo­cates $570M for Cana­di­an ex­pan­sion, looks to add 700 new jobs

4 months ago
R&D
Pharma

No­vo Nordisk’s amy­cretin prompts 22% weight loss in ear­ly obe­si­ty tri­al

4 months ago
R&D
China

Mod­er­na in­for­ma­tion chief to re­tire next month; Pharm­ing looks to Flag­ship for first new CEO since 2008

4 months ago
Peer Review

ALX On­col­o­gy to make case for ac­cel­er­at­ed ap­proval with new evor­pacept da­ta in gas­tric can­cer

4 months ago
R&D

Obe­si­ty biotech Aard­vark files for IPO to ad­vance oral, hunger-sup­press­ing drug

4 months ago
Financing
Startups

Unit­ed­Health Group names next in­sur­ance CEO, fol­low­ing top ex­ec­u­tive's mur­der

4 months ago
People
Health Tech

As an­oth­er Trump term gets un­der­way, phar­ma ad­vi­sors get com­fort­able with un­cer­tain­ty

4 months ago
Pharma
FDA+
First page Previous page 50515253545556 Next page Last page
A service from the Financial Times